CLDN4 and posterior cortical atrophy: Claudin-4 also has great potential for targeted delivery and imaging, designed to label PCa using quantum dots (QD), as a sensitive optical contrast agent, and to image PCa by using anti-CLDN4 as a targeting ligand.